Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial

Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial

Abstract Objective To compare the potential efficacy and safety of dual therapy and quadruple therapy with vonoprazan (VPZ) as well as the standard quadruple therapy of proton pump inhibitor (PPI) for the eradication of Helicobacter pylori (Hp) infection in Hainan province. Methods A single-centre,...

Full description

Bibliographic Details
Main Authors: Chen Chen, Daya Zhang, Shimei Huang, Fan Zeng, Da Li, Xiaodong Zhang, Runxiang Chen, Shiju Chen, Jun Wang, Feihu Bai
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Gastroenterology
Subjects:
Helicobacter pylori
Dual therapy
Quadruple therapy
Vonoprazan; non-inferiority
Online Access:https://doi.org/10.1186/s12876-024-03225-8

Internet

https://doi.org/10.1186/s12876-024-03225-8

Similar Items